Biotech

All Articles

Praxis epilepsy medication lessens confiscations in stage 2 trial

.Praxis Precision Medicines has actually racked up another midphase succeed in epilepsy this year, a...

Three directors resign as Dyne messages mixed data for DMD candidate

.After leaving a medical hold a number of years back, Dyne Therapeutics has disclosed new stage 1/2 ...

Arrowhead fires off stage 3 information in uncommon metabolic disease before market encounter Ionis

.Arrowhead Pharmaceuticals has shown its hand in advance of a prospective showdown with Ionis, relea...

Pfizer, Valneva present lyme disease go successful for 2nd enhancer

.Pfizer and also Valneva might have concerning 2 more years to wait before they help make the first ...

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Let's study a talk along with Ayla Ellison, Strong Biotech Editor-in-Chief and Michelle Benz as the...

New information show how Bayer's asundexian fell short to stop strokes

.Bayer suspended the period 3 test for its variable XIa inhibitor asundexian behind time in 2015 aft...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its own various sclerosis (MS) med tolebrutinib to the FDA, ...

Galapagos' stock up as fund presents intent to shape its own progression

.Galapagos is happening under added tension from clients. Having actually built a 9.9% risk in Galap...

Cell- focused Sana scoops 1st CSO-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings ...

Allist pays Jacobio $21M, landing job in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually purchased on its own a starring character in China's K...